Medtronic Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 6/28/2026)
| Balance Sheet | Total Assets | 93,026,000,000.00 | ROE | 53.17 % |
| Balance Sheet | Total Equity | 50,072,000,000.00 | ROA | 5.16 % |
| Cashflow | Capital Expenditures | -1,904,000,000.00 | P/FCF | 22.37 |
| Cashflow | Free Cash Flow | 5,426,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 7,330,000,000.00 | P/CF | 16.56 |
| Income | Earnings per Share (diluted) | 3.73 | Div. Yield | 3.01 % |
| Income | Net Income | 4,799,000,000.00 | P/E | 25.26 |
| Income | Shares Outstanding | 1,288,100,000.00 | P/B | 2.45 |
| Income | Total Revenue | 36,364,000,000.00 | P/S | 3.34 |
Ratios calculated on: 10/14/2026
Company Description
Medtronic, Inc. (Medtronic), is engaged in medical technology. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. In August 2013, Medtronic, Inc. announced the closing of the acquisition of Cardiocom. Effective September 3, 2013, Medtronic Inc acquired a 30% stake in NGC Medical SpA.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.medtronic.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more